ZIOP - ZIOPHARM Oncology Q3 2021 Earnings Preview
ZIOPHARM Oncology (NASDAQ:ZIOP) is scheduled to announce Q3 earnings results on Monday, November 8th, after market close. The consensus EPS Estimate is -$0.13 (-30.0% Y/Y). Ziopharm cut 60 positions -- more than half of its headcount -- as part of a cost reduction effort to extend its cash runway to 1H 2023, in September. The company's shares fell in reaction to posting Q2 earnings release and an analyst downgrade, in August. Over the last 2 years, ZIOP has beaten EPS estimates 13% of the time and has beaten revenue estimates 0% of the time. Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. The company's shares have fallen more than 34% year to date.
For further details see:
ZIOPHARM Oncology Q3 2021 Earnings Preview